Literature DB >> 25588802

Identification and quantification of macrophage presence in coronary atherosclerotic plaques by optical coherence tomography.

Luca Di Vito1, Manuela Agozzino2, Valeria Marco3, Andrea Ricciardi3, Monica Concardi2, Enrico Romagnoli3, Laura Gatto1, Giordano Calogero2, Luigi Tavazzi4, Eloisa Arbustini2, Francesco Prati5.   

Abstract

AIMS: Vulnerable plaques are characterized by a high macrophage content. We investigated the optical coherence tomography (OCT) capability of identifying coronary plaque macrophage presence using tissue property indexes. METHODS AND
RESULTS: Fifteen epicardial coronary arteries were imaged by OCT and subsequently analysed by histology. Correlating OCT-histological sections were identified and regions of interest (ROIs) were selected on both atherosclerotic plaques and normal appearing vessel tracts. OCT-derived tissue property indexes named normalized standard deviation (NSD), signal attenuation, and granulometry index were applied on ROIs to identify inflamed ROIs defined as a macrophage percentage >10 by histology. Forty-three paired samples (OCT frame and histology section) were considered suitable as ROIs for analysis. Eleven out of 43 ROIs were considered inflamed and the remaining 32 ROIs were non-inflamed on the basis of histological count of macrophage percentage. All OCT-derived tissue property indexes were positively correlated with macrophage percentage (P = 0.0001 for all). Receiver operating characteristic curve analysis showed that NSD, granulometry index, and signal attenuation had a significant area under the curve (area = 0.906, 0.804, and 0.793, respectively). A two-step algorithm requiring to first apply NSD with a cut-off value of 0.0570 followed by granulometry index was able to identify an inflamed ROI with a sensitivity of 100% and a specificity of 96.8%.
CONCLUSION: OCT was able to identify and quantify macrophage presence in coronary artery specimens using tissue property indexes. NSD and granulometry index showed the highest accuracy in identifying a significant plaque inflammation, especially if used together in a two-step algorithm. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  macrophage; normalized standard deviation; optical coherence tomography; vulnerable plaque

Mesh:

Year:  2015        PMID: 25588802     DOI: 10.1093/ehjci/jeu307

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  22 in total

1.  Intravascular optical coherence tomography [Invited].

Authors:  Brett E Bouma; Martin Villiger; Kenichiro Otsuka; Wang-Yuhl Oh
Journal:  Biomed Opt Express       Date:  2017-04-26       Impact factor: 3.732

2.  Endoscopic optical coherence tomography: technologies and clinical applications [Invited].

Authors:  Michalina J Gora; Melissa J Suter; Guillermo J Tearney; Xingde Li
Journal:  Biomed Opt Express       Date:  2017-04-07       Impact factor: 3.732

3.  Imaging: Focusing light on the vulnerable plaque.

Authors:  Peter J Psaltis; Stephen J Nicholls
Journal:  Nat Rev Cardiol       Date:  2016-05       Impact factor: 32.419

4.  Intravascular optical coherence tomography method for automated detection of macrophage infiltration within atherosclerotic coronary plaques.

Authors:  Jose J Rico-Jimenez; Daniel U Campos-Delgado; L Maximillan Buja; Deborah Vela; Javier A Jo
Journal:  Atherosclerosis       Date:  2019-09-28       Impact factor: 5.162

Review 5.  A Survey on Coronary Atherosclerotic Plaque Tissue Characterization in Intravascular Optical Coherence Tomography.

Authors:  Alberto Boi; Ankush D Jamthikar; Luca Saba; Deep Gupta; Aditya Sharma; Bruno Loi; John R Laird; Narendra N Khanna; Jasjit S Suri
Journal:  Curr Atheroscler Rep       Date:  2018-05-21       Impact factor: 5.113

6.  Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study.

Authors:  Nevio Taglieri; Cristina Nanni; Gabriele Ghetti; Rachele Bonfiglioli; Francesco Saia; Maria Letizia Bacchi Reggiani; Giacomo Maria Lima; Valeria Marco; Francesco Prati; Stefano Fanti; Claudio Rapezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-06       Impact factor: 9.236

7.  Coronary Atherosclerotic Phenotype and Plaque Healing in Patients With Recurrent Acute Coronary Syndromes Compared With Patients With Long-term Clinical Stability: An In Vivo Optical Coherence Tomography Study.

Authors:  Rocco Vergallo; Italo Porto; Domenico D'Amario; Gianmarco Annibali; Mattia Galli; Stefano Benenati; Francesco Bendandi; Stefano Migliaro; Francesco Fracassi; Cristina Aurigemma; Antonio Maria Leone; Antonino Buffon; Francesco Burzotta; Carlo Trani; Giampaolo Niccoli; Giovanna Liuzzo; Francesco Prati; Valentin Fuster; Ik-Kyung Jang; Filippo Crea
Journal:  JAMA Cardiol       Date:  2019-04-01       Impact factor: 14.676

8.  Clinical Characterization of Coronary Atherosclerosis With Dual-Modality OCT and Near-Infrared Autofluorescence Imaging.

Authors:  Giovanni J Ughi; Hao Wang; Edouard Gerbaud; Joseph A Gardecki; Ali M Fard; Ehsan Hamidi; Paulino Vacas-Jacques; Mireille Rosenberg; Farouc A Jaffer; Guillermo J Tearney
Journal:  JACC Cardiovasc Imaging       Date:  2016-03-09

9.  Repeatability Assessment of Intravascular Polarimetry in Patients.

Authors:  Martin Villiger; Kenichiro Otsuka; Antonios Karanasos; Pallavi Doradla; Jian Ren; Norman Lippok; Milen Shishkov; Joost Daemen; Roberto Diletti; Robert-Jan van Geuns; Felix Zijlstra; Jouke Dijkstra; Gijs van Soest; Evelyn Regar; Seemantini K Nadkarni; Brett E Bouma
Journal:  IEEE Trans Med Imaging       Date:  2018-07       Impact factor: 10.048

Review 10.  Molecular and Nonmolecular Imaging of Macrophages in Atherosclerosis.

Authors:  Zhaoyue Li; Hao Tang; Yingfeng Tu
Journal:  Front Cardiovasc Med       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.